ArticlePloS one2014

MGMT promoter methylation correlates with an overall survival benefit in Chinese high-grade glioblastoma patients treated with radiotherapy and alkylating agent-based chemotherapy: a single-institution study.

Dong Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.